Francesco Paolo Di Giorgio, PhD
Chief Executive Officer & Managing Director at Angelini Ventures, Italy
2007 NYSCF – Druckenmiller Fellow Alumnus
PhD, Harvard University
Postdoctoral Training, Salk Institute
Bio
Dr. Di Giorgio focused his research on Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease that targets brain cells responsible for motion. Stem cells are an important method to model ALS, as the complex nature of the disease has made it difficult to model and study. He derived large numbers of motor neurons from stem cells that survived long enough to be viable. He planned on conducting chemical screenings to find drugs that could slow or prevent neural degeneration. He completed his postdoctoral studies at the Salk Institute in Dr. Fred Gage’s lab.